Darius Ebrahimi-Fakhari
Darius Ebrahimi-Fakhari
Harvard Medical School, Boston Children's Hospital
Verified email at - Homepage
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Distinct roles in vivo for the ubiquitin–proteasome system and the autophagy–lysosomal pathway in the degradation of α-synuclein
D Ebrahimi-Fakhari, I Cantuti-Castelvetri, Z Fan, E Rockenstein, ...
Journal of Neuroscience 31 (41), 14508-14520, 2011
The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation
JO Lipton, ED Yuan, LM Boyle, D Ebrahimi-Fakhari, E Kwiatkowski, ...
Cell 161 (5), 1138-1151, 2015
N omenclature of genetic movement disorders: R ecommendations of the international P arkinson and movement disorder society task force
C Marras, A Lang, BP van de Warrenburg, CM Sue, SJ Tabrizi, L Bertram, ...
Movement Disorders 31 (4), 436-457, 2016
Protein degradation pathways in Parkinson’s disease: curse or blessing
D Ebrahimi-Fakhari, L Wahlster, PJ McLean
Acta neuropathologica 124, 153-172, 2012
The evolving spectrum of PRRT2-associated paroxysmal diseases
D Ebrahimi-Fakhari, A Saffari, A Westenberger, C Klein
Brain 138 (12), 3476-3495, 2015
Autism and the synapse: emerging mechanisms and mechanism-based therapies
D Ebrahimi-Fakhari, M Sahin
Current opinion in neurology 28 (2), 91-102, 2015
Abnormal mTOR activation in autism
KD Winden, D Ebrahimi-Fakhari, M Sahin
Annual review of neuroscience 41, 1-23, 2018
Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway
J Klucken, AM Poehler, D Ebrahimi-Fakhari, J Schneider, S Nuber, ...
Autophagy 8 (5), 754-766, 2012
Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex
D Ebrahimi-Fakhari, A Saffari, L Wahlster, A Di Nardo, D Turner, TL Lewis, ...
Cell reports 17 (4), 1053-1070, 2016
Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism
D Ebrahimi-Fakhari, A Saffari, L Wahlster, J Lu, S Byrne, GF Hoffmann, ...
Brain 139 (2), 317-337, 2016
Tuberous sclerosis complex
FJ DiMario, M Sahin, D Ebrahimi-Fakhari
Pediatric Clinics 62 (3), 633-648, 2015
Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study
D Ebrahimi-Fakhari, LL Mann, M Poryo, N Graf, R von Kries, B Heinrich, ...
Orphanet Journal of Rare Diseases 13, 1-8, 2018
Ante-, peri-and postnatal factors associated with intraventricular hemorrhage in very premature infants
M Poryo, JC Boeckh, L Gortner, M Zemlin, P Duppré, D Ebrahimi-Fakhari, ...
Early human development 116, 1-8, 2018
Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies
D Ebrahimi-Fakhari, LJ Saidi, L Wahlster
Acta neuropathologica communications 1, 1-15, 2013
EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy
S Byrne, L Jansen, JM U-King-Im, A Siddiqui, HGW Lidov, I Bodi, L Smith, ...
Brain 139 (3), 765-781, 2016
Molecular chaperones in Parkinson's disease–present and future
D Ebrahimi-Fakhari, L Wahlster, PJ McLean
Journal of Parkinson's disease 1 (4), 299-320, 2011
Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells
D Ebrahimi-Fakhari, L Wahlster, F Bartz, J Werenbeck-Ueding, ...
Human molecular genetics 25 (16), 3588-3599, 2016
Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force–an update
LM Lange, P Gonzalez‐Latapi, R Rajalingam, MAJ Tijssen, ...
Movement Disorders 37 (5), 905-935, 2022
Direct detection of alpha synuclein oligomers in vivo
H Dimant, SK Kalia, LV Kalia, LN Zhu, L Kibuuka, D Ebrahimi-Fakhari, ...
Acta neuropathologica communications 1, 1-10, 2013
The system can't perform the operation now. Try again later.
Articles 1–20